Apg Asset Management N.V. Incyte Corp Transaction History

Apg Asset Management N.V.

$15.7 Billion
Q3 2024

A detailed history of Apg Asset Management N.V. transactions in Incyte Corp stock. As of the latest transaction made, Apg Asset Management N.V. holds 147,192 shares of INCY stock, worth $10.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

147,192

Previous 783,288 81.21%

Holding current value

$10.1 Million

Previous $47.5 Million 79.51%

% of portfolio

0.06%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $36.5 Million - $43.6 Million	-636,096 Reduced 81.21%	147,192 $9.73 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $19.5 Million - $24.3 Million	-380,433 Reduced 32.69%	783,288 $47.5 Million
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $5.4 Million - $6.36 Million	95,519 Added 8.94%	1,163,721 $66.3 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $1.24 Million - $1.53 Million	23,836 Added 2.28%	1,068,202 $67.1 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $12 Million - $13.7 Million	207,560 Added 24.8%	1,044,366 $60.3 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $5.33 Million - $6.6 Million	-87,369 Reduced 9.45%	836,806 $52.1 Million
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $26.1 Million - $31.9 Million	-370,960 Reduced 28.64%	924,175 $66.8 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $10.3 Million - $12.9 Million	152,883 Added 13.38%	1,295,135 $104 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $26.3 Million - $32.9 Million	-397,066 Reduced 25.79%	1,142,252 $77.7 Million
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $30.2 Million - $37.9 Million	455,618 Added 42.04%	1,539,318 $112 Million
Q1 2022 May 12, 2022	SELL	$66.02 - $79.71 $475,344 - $573,912	-7,200 Reduced 0.66%	1,083,700 $77.4 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $14.1 Million - $16.5 Million	222,800 Added 25.67%	1,090,900 $70.4 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $1.12 Million - $1.37 Million	16,300 Added 1.91%	868,100 $51.5 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $37.3 Million - $40.9 Million	466,863 Added 121.28%	851,800 $60.4 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $905,930 - $1.2 Million	-11,917 Reduced 3.0%	384,937 $26.6 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $13.3 Million - $16.1 Million	164,869 Added 71.07%	396,854 $28.2 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $952,783 - $1.23 Million	-11,200 Reduced 4.61%	231,985 $17.8 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $8.77 Million - $12.9 Million	118,202 Added 94.57%	243,185 $22.5 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $4.96 Million - $6.76 Million	78,575 Added 169.31%	124,983 $9.15 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $53.6 Million - $72.9 Million	-848,303 Reduced 94.81%	46,408 $3.56 Million
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $8.3 Million - $10.9 Million	113,670 Added 14.55%	894,711 $69.6 Million
Q3 2019 Nov 08, 2019	BUY	$72.82 - $86.52 $48.8 Million - $58 Million	670,033 Added 603.59%	781,041 $53.2 Million
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $4.75 Million - $5.73 Million	64,600 Added 139.2%	111,008 $8.28 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $87,750 - $104,910	1,500 Added 3.34%	46,408 $2.58 Million
Q2 2018 Aug 13, 2018	BUY	$60.85 - $83.98 $115,615 - $159,562	1,900 Added 4.42%	44,908 $2.58 Million
Q4 2017 Jan 24, 2018	SELL	$93.56 - $116.6 $1.21 Million - $1.51 Million	-12,948 Reduced 23.14%	43,008 $3.39 Million
Q3 2017 Oct 19, 2017	BUY	$109.15 - $138.27 $6.11 Million - $7.74 Million	55,956	55,956 $6.53 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Incyte Corp Transaction History